Zhang Meijie, Cheng Luyang, Zhang Yina
Department of Geriatrics, The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.
Front Cell Dev Biol. 2020 Mar 31;8:184. doi: 10.3389/fcell.2020.00184. eCollection 2020.
The altered expression of long non-coding RNAs (lncRNAs) has been implicated in the development and human diseases. However, functional roles and regulatory mechanisms of lncRNA as competing endogenous RNAs (ceRNAs) in osteoporosis and their potential clinical implication for osteoporosis risk are largely unexplored. In this study, we performed integrated analysis for paired expression profiles and regulatory relationships of dysregulated lncRNAs, mRNAs, and miRNAs based on "ceRNA hypothesis," and constructed an osteoporosis-related dysregulated miRNA-mediated lncRNA-mRNA ceRNA network (DysCeNet) composed of 105 nodes (including eight miRNAs, 24 mRNAs, and 73 lncRNAs) and 515 edges. Functional analysis suggested that the DysCeNet was involved in known osteoporosis or bone metabolism-related biological processes and pathways. Then, we performed random forest-based feature selection for 73 lncRNAs with ceRNA activity and identified 25 of 73 lncRNAs as potential diagnostic biomarkers. A random forest-based classifier composed of 25 lncRNA biomarkers (RF-25lncRNA) was developed for predicting osteoporosis risk. Performance evaluation with the leave-one-out cross-validation (LOOCV) procedure showed that the RF-25lncRNA achieved a good performance in distinguishing high- and low-bone mineral density (BMD) subjects in different osteoporosis datasets. Our study for the first time revealed a global view of lncRNA-associated ceRNA regulation in osteoporosis and provided novel lncRNAs with ceRNA activity as candidate epigenetic diagnostic biomarkers for early detection of osteoporosis risk.
长链非编码RNA(lncRNAs)表达的改变与疾病的发生发展有关。然而,lncRNA作为竞争性内源性RNA(ceRNAs)在骨质疏松症中的功能作用、调控机制及其对骨质疏松症风险的潜在临床意义在很大程度上尚未得到探索。在本研究中,我们基于“ceRNA假说”对失调的lncRNAs、mRNAs和miRNAs的配对表达谱及调控关系进行了综合分析,并构建了一个由105个节点(包括8个miRNAs、24个mRNAs和73个lncRNAs)和515条边组成的骨质疏松症相关失调miRNA介导的lncRNA-mRNA ceRNA网络(DysCeNet)。功能分析表明,DysCeNet参与了已知的骨质疏松症或骨代谢相关的生物学过程和信号通路。然后,我们对具有ceRNA活性的73个lncRNAs进行了基于随机森林的特征选择,并确定其中25个lncRNAs为潜在的诊断生物标志物。开发了一个由25个lncRNA生物标志物组成的基于随机森林的分类器(RF-25lncRNA)来预测骨质疏松症风险。采用留一法交叉验证(LOOCV)程序进行的性能评估表明,RF-25lncRNA在区分不同骨质疏松症数据集中高骨密度(BMD)和低骨密度受试者方面表现良好。我们的研究首次揭示了lncRNA相关ceRNA调控在骨质疏松症中的整体情况,并提供了具有ceRNA活性的新型lncRNAs作为早期检测骨质疏松症风险的候选表观遗传诊断生物标志物。